Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The Toll-like receptor (TLR) family consists of phylogenetically conserved transmembrane proteins, which function as mediators of innate immunity for recognition of pathogen-derived ligands and subsequent cell activation via the Toll/IL-1R signal pathway. Here, we show that human TLR9 (hTLR9) expression in human immune cells correlates with responsiveness to bacterial deoxycytidylate-phosphate-deoxyguanylate (CpG)-DNA. Notably “gain of function” to immunostimulatory CpG-DNA is achieved by expressing TLR9 in human nonresponder cells. Transfection of either human or murine TLR9 conferred responsiveness in a CD14- and MD2-independent manner, yet required species-specific CpG-DNA motifs for initiation of the Toll/IL-1R signal pathway via MyD88. The optimal CpG motif for hTLR9 was GTCGTT, whereas the optimal murine sequence was GACGTT. Overall, these data suggest that hTLR9 conveys CpG-DNA responsiveness to human cells by directly engaging immunostimulating CpG-DNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: DNA-PKcs Is Required for Activation of Innate Immunity by Immunostimulatory DNA
Chu, W.-M., Gong, X., Li, Z.-W., Takabayashi, K., Ouyang, H.-H., Chen, Y., Lois, A., Chen, D. J., Li, G. C., Karin, M., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00194-x · Cited by 178
RetractedDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Self-citationHigh-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.-M., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,043
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,362
Self-citationToll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,076
Self-citation
Cited by
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Self-citationToll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
“Although there are few published reports on the expression of TLRs on each subset, TLR4 and TLR9 are expressed on monocyte-derived DCs (MDDCs) and plasmacytoid DCs (pDC2s), respectivel”
BackgroundSelf-citationToll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Self-citationThe immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E., Nilsen, N. J., Espevik, T., & Golenbock, D. T. (2004) · Nature Immunology · doi:10.1038/ni1028 · Cited by 1,361
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Self-citationPlasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Gilliet, M., Cao, W., & Liu, Y.-J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2358 · Cited by 1,190
“TLR9 seems to detect ssDNA molecules that contain unmethylated CpG-containing motifs, which are commonly found in the genomes of viruses and bacteri”
BackgroundRecognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150
Self-citationImmunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G., & Bauer, S. (2002) · Nature Immunology · doi:10.1038/ni0602-499 · Cited by 838
Self-citationSmith, K. D., Andersen-Nissen, E., Hayashi, F., Strobe, K., Bergman, M. A., Barrett, S. L. R., Cookson, B. T., & Aderem, A. (2003) · Nature Immunology · doi:10.1038/ni1011 · Cited by 808
GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large
Beutler, B., Jiang, Z., Georgel, P., Crozat, K., Croker, B., Rutschmann, S., Du, X., & Hoebe, K. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090552 · Cited by 772
Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Günther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1823 · Cited by 766
Krug, A., French, A. R., Barchet, W., Fischer, J. A. A., Dzionek, A., Pingel, J. T., Orihuela, M. M., Akira, S., Yokoyama, W. M., & Colonna, M. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.007 · Cited by 727
Self-citationAhmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717
Self-citationDunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
Staphylococcus aureus Biofilms Prevent Macrophage Phagocytosis and Attenuate Inflammation In Vivo
Thurlow, L. R., Hanke, M. L., Fritz, T., Angle, A., Aldrich, A., Williams, S. H., Engebretsen, I. L., Bayles, K. W., Horswill, A. R., & Kielian, T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002794 · Cited by 704
Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., & Colonna, M. (2004) · Blood · doi:10.1182/blood-2003-08-2674 · Cited by 695
Self-citationSynthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A., Alkan, S. S., & Vasilakos, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1259 · Cited by 683
Toll-like receptors: key mediators of microbe detection
Underhill, D. M., & Ozinsky, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00304-1 · Cited by 681
War and peace at mucosal surfaces
Sansonetti, P. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1499 · Cited by 679
Bernasconi, N. L., Onai, N., & Lanzavecchia, A. (2003) · Blood · doi:10.1182/blood-2002-11-3569 · Cited by 667
Structure and Function of Toll Receptors and Their Ligands
Gay, N. J., & Gangloff, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.151318 · Cited by 667
siRNA vs. shRNA: Similarities and differences
Rao, D. D., Vorhies, J. S., Senzer, N., & Nemunaitis, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 660
Speiser, D. E., Líénard, D., Rufer, N., Rubio‐Godoy, V., Rimoldi, D., Lejeune, F. J., Krieg, A. Μ., Cerottini, J., & Romero, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523373 · Cited by 640
Vollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H. L., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324032 · Cited by 595
How we detect microbes and respond to them: the Toll-like receptors and their transducers
Beutler, B., Hoebe, K., Du, X., & Ulevitch, R. J. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0203082 · Cited by 591
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Vollmer, J., & Krieg, A. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.008 · Cited by 585
Akira, S. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00013-4 · Cited by 584
Self-citationParroche, P., Lauw, F. N., Goutagny, N., Latz, E., Monks, B. G., Visintin, A., Halmen, K. A., Lamphier, M., Olivier, M., Bartholomeu, D. C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608745104 · Cited by 575
Role of Toll-Like Receptors in Pathogen Recognition
Janssens, S., & Beyaert, R. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.637-646.2003 · Cited by 574
Edwards, A. D., Diebold, S. S., Slack, E. M. C., Tomizawa, H., Hemmi, H., Kaisho, T., Akira, S., & Sousa, C. R. E. (2003) · European Journal of Immunology · doi:10.1002/eji.200323797 · Cited by 551
Self-citationNew Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 533
Okshevsky, M., & Meyer, R. L. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.841639 · Cited by 526
Activation of Autoreactive B Cells by CpG dsDNA
Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J., & Marshak-Rothstein, A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00323-6 · Cited by 521
Heil, F., Ahmad‐Nejad, P., Hemmi, H., Hochrein, H., Ampenberger, F., Gellert, T., Dietrich, H., Lipford, G., Takeda, K., Akira, S., et al. (2003) · European Journal of Immunology · doi:10.1002/eji.200324238 · Cited by 518
Self-citationBellocchio, S., Montagnoli, C., Bozza, S., Gaziano, R., Rossi, G., Mambula, S. S., Vecchi, A., Mantovani, A., Levitz, S. M., & Romani, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3059 · Cited by 515
“Breeding pairs of homozygous TLR2- (36), TLR4- (37), TLR9(38), IL-1RI- (39), and MyD88- (40) deficient mice, raised on the C57BL6 background, were bred under specific pathogen-free conditions at the breeding facilities of University of Perugia (Perugia, Italy) or Boston University Medical Center.”
MethodToll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner
Rutz, M., Metzger, J., Gellert, T., Luppa, P., Lipford, G. B., Wagner, H., & Bauer, S. (2004) · European Journal of Immunology · doi:10.1002/eji.200425218 · Cited by 503
Self-citationSteinhagen, F., Kinjo, T., Bode, C., & Klinman, D. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.08.002 · Cited by 501
Toll-like receptors as adjuvant receptors
Kaisho, T., & Akira, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00182-3 · Cited by 492
Self-citationGroeger, S., & Meyle, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00208 · Cited by 473
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Ivanov, S., Dragoi, A.-M., Wang, X., Dallacosta, C., Louten, J., Musco, G., Sitia, G., Yap, G. S., Wan, Y., Biron, C. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-044776 · Cited by 470
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Moyle, P. M., & Toth, I. (2013) · ChemMedChem · doi:10.1002/cmdc.201200487 · Cited by 464
Sivori, S., Falco, M., Chiesa, M. D., Carlomagno, S., Vitale, M., Moretta, L., & Moretta, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403744101 · Cited by 455
Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals
Vidya, M. K., Kumar, V. G., Sejian, V., Bagath, M., Krishnan, G., & Bhatta, R. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2017.1380200 · Cited by 442
Stils, H. F. (2005) · ILAR Journal · doi:10.1093/ilar.46.3.280 · Cited by 434
Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family
Martin, M. U., & Wesche, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00320-8 · Cited by 426
Brinkmann, M. M., Spooner, E., Hoebe, K., Beutler, B., Ploegh, H. L., & Kim, Y.-M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612056 · Cited by 411
Innate immune responses to infection
Tosi, M. F. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.036 · Cited by 391
Toll‐like receptors, endogenous ligands, and systemic autoimmune disease
Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G., & Marshak‐Rothstein, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00239.x · Cited by 389
NK cells at the interface between innate and adaptive immunity
Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G., & Moretta, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402170 · Cited by 387
Bourke, E., Bosisio, D., Golay, J., Polentarutti, N., & Mantovani, A. (2003) · Blood · doi:10.1182/blood-2002-11-3355 · Cited by 384
Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
Ohto, U., Shibata, T., Tanji, H., Ishida, H., Krayukhina, E., Uchiyama, S., Miyake, K., & Shimizu, T. (2015) · Nature · doi:10.1038/nature14138 · Cited by 377
Gibson, S. J., Lindh, J. M., Riter, T. R., Gleason, R. M., Rogers, L. M., Fuller, A. E., Oesterich, J. L., Gorden, K. B., Qiu, X., McKane, S. W., et al. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00517-8 · Cited by 375
Köllisch, G., Kalali, B. N., Voelcker, V., Wallich, R., Behrendt, H., Ring, J., Bauer, S., Jakob, T., Mempel, M., & Ollert, M. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02122.x · Cited by 358
Self-citationMITOCHONDRIAL DNA IS RELEASED BY SHOCK AND ACTIVATES NEUTROPHILS VIA P38 MAP KINASE
Zhang, Q., Itagaki, K., & Hauser, C. J. (2010) · Shock · doi:10.1097/shk.0b013e3181cd8c08 · Cited by 354
Kerkmann, M., Rothenfusser, S., Hornung, V., Towarowski, A., Wagner, M., Sarris, A., Giese, T., Endres, S., & Hartmann, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4465 · Cited by 352
Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Krieg, A. M., & Vollmer, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00572.x · Cited by 350
Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN
Bekeredjian-Ding, I. B., Wagner, M., Hornung, V., Giese, T., Schnurr, M., Endres, S., & Hartmann, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4043 · Cited by 349
A Decade of Advances in Iridovirus Research
Williams, T., Barbosa‐Solomieu, V., & Chinchar, V. G. (2005) · Advances in Virus Research · doi:10.1016/s0065-3527(05)65006-3 · Cited by 344
The immunobiology of the TLR9 subfamily
Wagner, H. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.04.011 · Cited by 341
Self-citationHemmi, H., Kaisho, T., Takeda, K., & Akira, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3059 · Cited by 340
Self-citationTLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway
Moynagh, P. N. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.009 · Cited by 336
Boehme, K. W., Guerrero, M., & Compton, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7094 · Cited by 331
Wang, H., Li, T., Chen, S., Gu, Y., & Ye, S. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39296 · Cited by 325
“5 mg/day at baseline 41 (73) 45 (79) Immunosuppressive drugs Mycophenolate 13 (23) 15 (26) Azathioprine 7 (13) 7 (13) Methotrexate 12 (21) 6 (11) Leflunomide 1 (2) 0 (0) Cyclosporine 0 (0) 5 (9) Thalidomide 4 (7) 3 (5) Cyclophosphamide 3 (5) 4 (7) Antimalarials 52 (92) 51 (89) Biomarkers Anti-dsDNA, IU/ml† 30.”
BackgroundInfluentialImmunity in response to particulate antigen-delivery systems
STORNI, T., KUNDIG, T., SENTI, G., & JOHANSEN, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.008 · Cited by 317
Harton, J. A., Linhoff, M. W., Zhang, J., & Ting, J. P.-Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4088 · Cited by 316
TLR7/8-Mediated Activation of Human NK Cells Results in Accessory Cell-Dependent IFN-γ Production
Hart, O. M., Athie-Morales, V., O’Connor, G. M., & Gardiner, C. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1636 · Cited by 310
Regulation of the nucleic acid-sensing Toll-like receptors
Lind, N. A., Rael, V. E., Pestal, K., Liu, B., & Barton, G. M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00577-0 · Cited by 307
Use of CpG oligodeoxynucleotides as immune adjuvants
Klinman, D. M., Currie, D., Gursel, I., & Verthelyi, D. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00148.x · Cited by 306
Induction of Antiviral Immunity by Double-Stranded RNA in a Marine Invertebrate
Robalino, J., Browdy, C. L., Prior, S., Metz, A., Parnell, P., Gross, P., & Warr, G. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10442-10448.2004 · Cited by 306
Nagase, H., Okugawa, S., Ota, Y., Yamaguchi, M., Tomizawa, H., Matsushima, K., Ohta, K., Yamamoto, K., & Hirai, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.3977 · Cited by 305
Poeck, H., Wagner, M., Battiany, J., Rothenfusser, S., Wellisch, D., Hornung, V., Jahrsdorfer, B., Giese, T., Endres, S., & Hartmann, G. (2004) · Blood · doi:10.1182/blood-2003-08-2972 · Cited by 303
Guillot, L., Balloy, V., McCormack, F. X., Golenbock, D. T., Chignard, M., & Si-Tahar, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.5989 · Cited by 299
The host–microbe interface within the gut
Shanahan, F. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0342 · Cited by 299
The DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
Haas, T., Metzger, J., Schmitz, F., Heit, A., Müller, T., Latz, E., & Wagner, H. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.013 · Cited by 298
Self-citationHartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S., & Endres, S. (2003) · European Journal of Immunology · doi:10.1002/eji.200323813 · Cited by 296
He, B., Qiao, X., & Cerutti, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4479 · Cited by 296
Some interfaces of dendritic cell biology
STEINMAN, R. M. (2003) · APMIS · doi:10.1034/j.1600-0463.2003.11107802.x · Cited by 292
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity
Marciani, D. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02864-2 · Cited by 290
Signal integration between IFNγ and TLR signalling pathways in macrophages
Schroder, K., Sweet, M. J., & Hume, D. A. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.007 · Cited by 288
Jing, Y., Shaheen, E., Drake, R. R., Chen, N., Gravenstein, S., & Deng, Y. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.07.005 · Cited by 284
“Because the IFN-α secretion is known to be mediated via TLR-7 and TLR-9 when stimulated by influenza viruses and CpG, respectively[36,37], these results suggest that the TLR-7 and TLR-9 expression/signaling pathway on pDC is impaired by aging.”
BackgroundIdentification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses
Forsbach, A., Nemorin, J.-G., Montino, C., Müller, C., Samulowitz, U., Vicari, A. P., Jurk, M., Mutwiri, G. K., Krieg, A. M., Lipford, G. B., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3729 · Cited by 281
Self-citationGoldammer, T., Zerbe, H., Molenaar, A., Schuberth, H.-J., Brunner, R. M., Kata, S. R., & Seyfert, H.-M. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.1.174-185.2004 · Cited by 281
Pinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G.-J., & Leibovich, S. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63698-x · Cited by 278
“TLR9 has been shown to be the receptor for non-methylated C-G rich DNA (CpG DNA).(10,11) The antiviral imidazoquinoline resiquimod (R-848) has been shown recently to be a TLR7 agonist in mice.”
BackgroundInfluentialThe role of Toll-like receptors and neuroinflammation in Parkinson’s disease
Heidari, A., Yazdanpanah, N., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02496-w · Cited by 275
“Alternatively, endosome-associated TLRs (TLR 3, 7, 8, and 9) are specific to both selfderived and pathogen-related nucleic acids, like viral double- or single-stranded RNAs, and bacterial- or viralrelated cytosine phosphate guanine (CpG) motif of DNA [28, 29].”
BackgroundLien, E., & Ingalls, R. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00001 · Cited by 273
Yang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C.-L., Casrouge, A., Picard, C., von Bernuth, H., Senechal, B., Plancoulaine, S., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.016 · Cited by 272
CpG motifs: the active ingredient in bacterial extracts?
Krieg, A. M. (2003) · Nature Medicine · doi:10.1038/nm0703-831 · Cited by 271
Montanaro, L., Poggi, A., Visai, L., Ravaioli, S., Campoccia, D., Speziale, P., & Arciola, C. R. (2011) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000051 · Cited by 270
López, M., Sly, L. M., Luu, Y., Young, D., Cooper, H., & Reiner, N. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2409 · Cited by 269
Toll-like Receptors and Their Signaling Mechanisms
Akira, S., & Sato, S. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310015683 · Cited by 265
Self-citation
Metadata
- Authors
- Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-07-24
- Volume
- 98
- Issue
- 16
- Pages
- 9237-9242
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2069981713
- Cited by
- 1,533
- References
- 44
- FWCI
- 31.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.